Article

Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancer

2024-05-24

Abstract excerpt

<title>Abstract</title> <p>Purpose: Bladder cancer (BLCA) is a highly heterogeneous tumor. We aim to construct a classifier from the perspective of N6-methyladenosine methylation (m6A) to identify patients with different prognostic risks and treatment responsiveness for precision therapy. METHODS: Data of gene expression profile, mutation, and clinical characteristics were mainly obtained from the TCGA-BLCA cohor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7183ca5c-1fd3-509e-b6d9-73d88d3dc70d
DOI: 10.21203/rs.3.rs-4413908/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancerDOI 10.21203/rs.3.rs-4413908/v1Read

Identification of a novel RNA modifications-related model to improve bladder cancer outcomes in the framework of predictive, preventive, and personalized medicineSemantic proximity Read

5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancerSemantic proximity Read

N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancerSemantic proximity Read

Integrating Stemness Features and Immune Microenvironment in a Prognostic Model for Bladder Cancer TreatmentSemantic proximity Read

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder CancerSemantic proximity Read

Multi-Omics Analysis Identifies the Heterogeneity and Prognosis in Bladder CancerSemantic proximity Read

Significance of KDM6A Mutation in Bladder Cancer Immune EscapeSemantic proximity Read

An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancerSemantic proximity Read

Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer.Semantic proximity Read

Identification and Validation of N6-methyladenosine-related Biomarkers for Bladder Cancer: Implications for ImmunotherapySemantic proximity Read

Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine developmentSemantic proximity Read

M5C modulator mediated methylation pattern and TME cell infiltration in bladder cancerSemantic proximity Read